本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Atara Biotherapeutics

9.44
+0.19002.05%
成交量:5.61萬
成交額:51.83萬
市值:9,475.59萬
市盈率:-7.94
高:9.88
開:9.21
低:8.92
收:9.25
52周最高:19.15
52周最低:3.92
股本:1,003.77萬
流通股本:462.30萬
量比:1.06
換手率:1.21%
股息:- -
股息率:- -
每股收益(TTM):-1.1889
每股收益(LYR):2.57
淨資產收益率:-2014.86%
總資產收益率:-24.14%
市淨率:-2.56
市盈率(LYR):3.67

資料載入中...

2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

重要事件披露

8-K - Current report
2022/01/10

重要事件披露

8-K - Current report
2022/01/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/18

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/18

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/18

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/18

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/18

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/04

重要事件披露

8-K - Current report
2021/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/04

重要事件披露

8-K - Current report
2021/09/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/10

重要事件披露

8-K - Current report